English
Français
Deutsch
Italiano
Русский
Español
हिन्दी
简体中文
한국어
日本語
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Shareholder/Analyst Call October 7, 2025 8:30 AM EDT
Company Participants
D. Walke – Senior Vice President of Investor Relations
Brett Monia – Founder, CEO & Director
Sotirios Tsimikas – Senior Vice President of Global Cardiovascular Development
Kyle Jenne – Executive VP & Chief Global Product Strategy Officer
Kenneth Newman – Senior Vice President of Clinical Development
Holly Kordasiewicz – Senior Vice President of Neurology
Elizabeth L. Hougen – Executive VP of Finance & CFO
Conference Call Participants
Robert D. Fishberg
Huidong Wang – Barclays Bank PLC, Research Division
Yanan Zhu – Wells Fargo Securities, LLC, Research Division
Jason Gerberry – BofA Securities, Research Division
Debjit Chattopadhyay – Guggenheim Securities, LLC, Research Division
Jay Olson – Oppenheimer & Co. Inc., Research Division
Arsalan Kamran
Salveen Richter – Goldman Sachs Group, Inc., Research Division
Jessica Fye – JPMorgan Chase & Co, Research Division
Julian Pino – Stifel, Nicolaus & Company, Incorporated, Research Division
Yale Jen – Laidlaw & Company (UK) Ltd., Research Division
Shelby Tucker
Ryan Mcelroy – Leerink Partners LLC, Research Division
Zaki Molvi – Jefferies LLC, Research Division
Conversation
D. Walke
Senior Vice President of Investor Relations
Good morning, and welcome, everyone, to Ionis Pharmaceuticals 2025 Innovation Day. I’m Wade Walke, Head of Investor Relations. And it’s great to see so many of you here in the room with us today. We’d also like to welcome those who are joining us today online via our webcast.
Every 2 years, we host this meeting in order to give you an update on the progress we’re making on our goal to transform the lives of people with unmet — severe unmet medical needs. And today, we are thrilled to showcase how we are leveraging our technology, our pipeline and our medicines to accelerate growth and to deliver transformative medicines to patients.
Before we begin, a brief note that we will be making forward-looking statements today that are
Read the full article here
